Reining in
High-Cost
Generic Spend
High-Cost
Generic Spend
THE CHALLENGE
It is a common misconception that all generic drugs are inexpensive. Now, as expensive specialty medications are gaining approvals and demand for GLP-1s continues to rise, reining in spend for generics has become more important than ever. To deliver real savings for payers and members, MedImpact has designed three solutions aimed at addressing high-cost generics (HCG): HCG Choice®, HCG X®, and HCG Select®.
AN AGILE APPROACH
Developed using our clinical expertise and advanced analytics, we identify and track list prices, MACs, and claim costs for more than 2,000 generic drugs. This allows us to quickly respond to price changes and maximize cost-saving opportunities.
HCG X
For smarter spending without compromising care, HCG X identifies and excludes high-cost generic drugs and brand equivalents when there are clinically appropriate, lower-cost generic alternatives. After just one year of using this award-winning program, clients experienced:
